Morgan Stanley Reiterates Overweight on WUXI APPTEC, Raises Target Price to HK$143.5

Stock News

Feb 20

Morgan Stanley has issued a research report reaffirming an "Overweight" rating for WUXI APPTEC (02359). Following the company's previously disclosed preliminary 2025 results, which showed improved gross margins, the firm has raised its profit forecasts for 2026 to 2030 by 0% to 3%. As a result, the target price has been increased from HK$143 to HK$143.5. The bank anticipates a compound annual growth rate of 24% in profits from 2024 to 2027. It remains optimistic about the company's unique CRDMO/CTDMO model and platform advantages, along with its leading number of early-stage projects among Chinese competitors. These factors are expected to provide stronger visibility for medium- to long-term growth compared to domestic peers.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/news/1111237097"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1111237097\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1111237097?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-02-20 17:16","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1111237097","market":"fut","top_or_hot":-1,"title":"Morgan Stanley Reiterates Overweight on WUXI APPTEC, Raises Target Price to HK$143.5","media":"Stock News","content":"<p>Morgan Stanley has issued a research report reaffirming an \"Overweight\" rating for WUXI APPTEC (02359). Following the company's previously disclosed preliminary 2025 results, which showed improved gross margins, the firm has raised its profit forecasts for 2026 to 2030 by 0% to 3%. As a result, the target price has been increased from HK$143 to HK$143.5. The bank anticipates a compound annual growth rate of 24% in profits from 2024 to 2027. It remains optimistic about the company's unique CRDMO/CTDMO model and platform advantages, along with its leading number of early-stage projects among Chinese competitors. These factors are expected to provide stronger visibility for medium- to long-term growth compared to domestic peers.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Morgan Stanley Reiterates Overweight on WUXI APPTEC, Raises Target Price to HK$143.5</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nMorgan Stanley Reiterates Overweight on WUXI APPTEC, Raises Target Price to HK$143.5\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036600163\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/b3bf6d02ad1a6e9e7377eebbb162346a);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock News </p>\n<p class=\"h-time\">2026-02-20 17:16</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Morgan Stanley has issued a research report reaffirming an \"Overweight\" rating for WUXI APPTEC (02359). Following the company's previously disclosed preliminary 2025 results, which showed improved gross margins, the firm has raised its profit forecasts for 2026 to 2030 by 0% to 3%. As a result, the target price has been increased from HK$143 to HK$143.5. The bank anticipates a compound annual growth rate of 24% in profits from 2024 to 2027. It remains optimistic about the company's unique CRDMO/CTDMO model and platform advantages, along with its leading number of early-stage projects among Chinese competitors. These factors are expected to provide stronger visibility for medium- to long-term growth compared to domestic peers.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"LU1997244956.HKD","symbol_name":"ALLIANZ CHINA A-SHARES \"AT\" (HKD) ACC A","start_time":0,"source_url":"","article_id":"1111237097","we_media_id":"1036600163","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1111237097","pubTimestamp":1771578975,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Stock News","introduction":"Global Stock News First-Time Broadcast","home_visible":1,"id":"1036600163","head_image":"https://community-static.tradeup.com/news/b3bf6d02ad1a6e9e7377eebbb162346a"},"summary":"Morgan Stanley has issued a research report reaffirming an \"Overweight\" rating for WUXI APPTEC (02359). Following the company's previously disclosed preliminary 2025 results, which showed improved...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"603259":"药明康德","LU1997244956.HKD":"ALLIANZ CHINA A-SHARES \"AT\" (HKD) ACC A","LU2242644610.SGD":"Fidelity China Innovation A-ACC-SGD","BK1576":"医药外包概念","BK1141":"生命科学工具和服务","LU1997245177.USD":"安联神洲A股基金","LU2328871848.SGD":"Eastspring Investments - China A Shares Growth AS SGD","LU1808992512.USD":"AB ALL CHINA EQUITY PORTFOLIO \"A\" (USD) ACC","02359":"药明康德","LU0456842615.SGD":"JPMorgan Funds - Emerging Markets Equity A (acc) SGD","LU2488822045.USD":"ALLIANZ CHINA HEALTHY LIVING \"AT\" (USD) ACC","LU2045819591.USD":"Natixis WCM Global Emerging Markets Equity R/A USD","LU0052750758.USD":"富兰克林中国基金A Acc","LU0320764599.SGD":"FTIF - Templeton China A Acc SGD","LU1969619763.USD":"EASTSPRING INV CHINA A SHARES GROWTH \"A\" (USD) ACC","LU1997245094.SGD":"安联神州A股基金AT Acc SGD","LU0708995583.HKD":"TEMPLETON CHINA \"A\" (HKD) ACC","BK1583":"高瓴概念","BK0216":"研究试验","LU2125910500.SGD":"Natixis WCM Global Emerging Markets Equity H-R/A SGD","LU1934453819.USD":"AB CHINA A SHARES EQUITY PORTFOLIO \"A\" (USD) ACC","LU1979443071.USD":"AB CHINA A SHARES EQUITY PORTFOLIO \"AD\" (USDHDG) INC","LU2495084118.USD":"ALLIANZ CHINA A-SHARES \"ATH\" (USDHDG) ACC","LU1046422090.SGD":"Fidelity Pacific A-SGD"},"translate_title":"大摩重申跑赢大盘药明康德上调目标价至143.5港元","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"603259":1,"02359":1},"content_text":"Morgan Stanley has issued a research report reaffirming an \"Overweight\" rating for WUXI APPTEC (02359). Following the company's previously disclosed preliminary 2025 results, which showed improved gross margins, the firm has raised its profit forecasts for 2026 to 2030 by 0% to 3%. As a result, the target price has been increased from HK$143 to HK$143.5. The bank anticipates a compound annual growth rate of 24% in profits from 2024 to 2027. It remains optimistic about the company's unique CRDMO/CTDMO model and platform advantages, along with its leading number of early-stage projects among Chinese competitors. These factors are expected to provide stronger visibility for medium- to long-term growth compared to domestic peers.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"shareholding","news_rank":0,"symbols":[],"gpt_button":1,"need_auth":false,"code":"91000000","status":"200"}}}